Loading resource…
Emory University
The document outlines clinical practice guidelines co-sponsored by the American Association for the Study of Liver Diseases and the American Association of Clinical Endocrinology. It addresses the complexities of diagnosing and managing NAFLD, including the role of obesity and diabetes in disease progression. The guidelines highlight the need for lifestyle changes and the current lack of FDA-approved medications for treating NASH, while also acknowledging the limitations of existing studies and the necessity for ongoing updates as new research emerges.
No account needed